Clinical Trials Browser

Leukemia, Myeloid × asciminib × 30 days × Clear all

NCT05143840 2026-06-02

ALERTCML

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT07604233 2026-06-01

Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML

Phase 1/2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid